Medtronic Price to Sales Ratio 2012-2026 | MDT
Historical PS ratio values for Medtronic (MDT) over the last 10 years. The current P/S ratio for Medtronic as of March 11, 2026 is .
| Medtronic P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2026-03-12 | 87.38 | 3.17 | |
| 2026-01-31 | 102.96 | $27.54 | 3.74 |
| 2025-10-31 | 90.04 | $26.99 | 3.34 |
| 2025-07-31 | 88.91 | $26.56 | 3.35 |
| 2025-04-30 | 82.82 | $26.00 | 3.19 |
| 2025-01-31 | 88.04 | $25.54 | 3.45 |
| 2024-10-31 | 85.78 | $25.17 | 3.41 |
| 2024-07-31 | 76.59 | $24.63 | 3.11 |
| 2024-04-30 | 75.84 | $24.30 | 3.12 |
| 2024-01-31 | 82.06 | $24.25 | 3.38 |
| 2023-10-31 | 65.59 | $23.98 | 2.74 |
| 2023-07-31 | 80.89 | $23.68 | 3.42 |
| 2023-04-30 | 83.18 | $23.43 | 3.55 |
| 2023-01-31 | 75.89 | $23.00 | 3.30 |
| 2022-10-31 | 78.50 | $22.95 | 3.42 |
| 2022-07-31 | 82.50 | $23.05 | 3.58 |
| 2022-04-30 | 92.34 | $23.41 | 3.94 |
| 2022-01-31 | 91.03 | $23.47 | 3.88 |
| 2021-10-31 | 104.76 | $23.46 | 4.47 |
| 2021-07-31 | 114.21 | $23.33 | 4.90 |
| 2021-04-30 | 113.30 | $22.26 | 5.09 |
| 2021-01-31 | 95.86 | $20.65 | 4.64 |
| 2020-10-31 | 86.17 | $20.62 | 4.18 |
| 2020-07-31 | 82.20 | $20.67 | 3.98 |
| 2020-04-30 | 82.63 | $21.39 | 3.86 |
| 2020-01-31 | 97.10 | $22.96 | 4.23 |
| 2019-10-31 | 91.17 | $22.82 | 3.99 |
| 2019-07-31 | 84.91 | $22.62 | 3.75 |
| 2019-04-30 | 73.57 | $22.48 | 3.27 |
| 2019-01-31 | 72.82 | $22.44 | 3.25 |
| 2018-10-31 | 73.58 | $22.30 | 3.30 |
| 2018-07-31 | 73.55 | $21.96 | 3.35 |
| 2018-04-30 | 64.93 | $21.93 | 2.96 |
| 2018-01-31 | 69.20 | $21.67 | 3.19 |
| 2017-10-31 | 64.51 | $21.49 | 3.00 |
| 2017-07-31 | 66.88 | $21.60 | 3.10 |
| 2017-04-30 | 65.83 | $21.32 | 3.09 |
| 2017-01-31 | 59.91 | $20.94 | 2.86 |
| 2016-10-31 | 64.26 | $20.55 | 3.13 |
| 2016-07-31 | 68.31 | $20.21 | 3.38 |
| 2016-04-30 | 61.40 | $20.19 | 3.04 |
| 2016-01-31 | 58.59 | $21.47 | 2.73 |
| 2015-10-31 | 56.77 | $20.93 | 2.71 |
| 2015-07-31 | 59.87 | $20.38 | 2.94 |
| 2015-04-30 | 56.58 | $19.57 | 2.89 |
| 2015-01-31 | 54.05 | $17.49 | 3.09 |
| 2014-10-31 | 51.38 | $17.27 | 2.97 |
| 2014-07-31 | 46.31 | $17.03 | 2.72 |
| 2014-04-30 | 43.91 | $16.78 | 2.62 |
| 2014-01-31 | 42.03 | $16.62 | 2.53 |
| 2013-10-31 | 42.45 | $16.44 | 2.58 |
| 2013-07-31 | 40.64 | $16.27 | 2.50 |
| 2013-04-30 | 34.15 | $16.13 | 2.12 |
| 2013-01-31 | 33.91 | $15.85 | 2.14 |
| 2012-10-31 | 30.07 | $15.60 | 1.93 |
| 2012-07-31 | 28.34 | $15.40 | 1.84 |
| 2012-04-30 | 27.28 | $15.22 | 1.79 |
| 2012-01-31 | 27.38 | $14.84 | 1.84 |
| 2011-10-31 | 24.50 | $14.73 | 1.66 |
| 2011-07-31 | 25.23 | $14.54 | 1.73 |
| 2011-04-30 | 29.04 | $14.32 | 2.03 |
| 2011-01-31 | 26.50 | $14.04 | 1.89 |
| 2010-10-31 | 24.21 | $13.94 | 1.74 |
| 2010-07-31 | 25.24 | $13.79 | 1.83 |
| 2010-04-30 | 29.64 | $13.86 | 2.14 |
| 2010-01-31 | 28.97 | $13.86 | 2.09 |
| 2009-10-31 | 24.00 | $13.50 | 1.78 |
| 2009-07-31 | 23.68 | $13.20 | 1.79 |
| 2009-04-30 | 21.26 | $12.95 | 1.64 |
| 2009-01-31 | 22.11 | $12.92 | 1.71 |
| 2008-10-31 | 26.46 | $12.81 | 2.07 |
| 2008-07-31 | 34.53 | $12.37 | 2.79 |
| 2008-04-30 | 31.70 | $11.81 | 2.68 |
| 2008-01-31 | 30.20 | $11.26 | 2.68 |
| 2007-10-31 | 30.74 | $10.88 | 2.83 |
| 2007-07-31 | 32.76 | $10.81 | 3.03 |
| 2007-04-30 | 34.14 | $10.58 | 3.23 |
| 2007-01-31 | 34.40 | $10.28 | 3.35 |
| 2006-10-31 | 31.26 | $9.92 | 3.15 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $127.548B | $33.537B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Sanuwave Health (SNWV) | United States | $0.213B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |